Genome Editing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Genome Editing Market Overview and the Market is segmented by Technology (Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc Finger Nuclease (ZFN), and Other Technologies), Application (Cell Line Editing, Animal Genome Editing, Plant Genome Editing, and Others), End User (Pharmaceutical companies and Biotechnology Companies, Academics and Government Research Institutes, and Clinical Research Organizations), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market Size and Values Are Provided in Terms of (USD Million) During the Forecasted Years for the Above Segments.

Genome Editing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Genome Editing Industry Overview

The market is partially fragmented and consists of several major players. Most of the players are based in developing counties due to more technological advancements. But due to the ease of connectivity in modern times, these players have also penetrated developing countries and are trying to establish a market in these countries as well. High growth potential in emerging regions provides new opportunities to industry players. Some of the companies which are currently dominating the market are GenScript USA Inc., Integrated DNA Technologies Inc., New England Biolabs Inc., Sangamo Biosciences Inc., and Thermo Fisher Scientific Inc. among others.

Genome Editing Market Leaders

  1. GenScript USA Inc.

  2. Integrated DNA Technologies Inc.

  3. New England Biolabs Inc.

  4. Sangamo Biosciences Inc.

  5. Thermo Fisher Scientific Inc.

  6. Genscript Biotech Corp

  7. *Disclaimer: Major Players sorted in no particular order
Genome Editing Market Concentration